이소잘루자닌 C를 포함하는, 알레르기 또는 염증성 질환의 예방 또는 치료용 조성물
    7.
    发明公开
    이소잘루자닌 C를 포함하는, 알레르기 또는 염증성 질환의 예방 또는 치료용 조성물 有权
    包含ISOZALUZANIN C用于预防或治疗过敏症的组合物

    公开(公告)号:KR1020130134900A

    公开(公告)日:2013-12-10

    申请号:KR1020120058771

    申请日:2012-05-31

    Inventor: 마응천 신종헌

    Abstract: The present invention relates to a composition with isozaluzanin C for preventing or treating allergy or inflammatory diseases. The composition according to one embodiment of the present invention includes isozaluzanin C as an effective element. [Reference numerals] (AA) Emission of 棺-hexosaminidase (%);(BB) Isozaluzanin C;(CC) ketotifen

    Abstract translation: 本发明涉及具有用于预防或治疗过敏或炎性疾病的异恶唑烷酮C的组合物。 根据本发明的一个实施方案的组合物包括作为有效成分的异恶唑烷酮C. [AA](AA)(AA)的排出物(%);(BB)异恶唑烷酮C(CC)酮替芬

    월계수 잎의 단일성분 추출물을 함유한 파킨슨병과 퇴행성 신경계 뇌질환의 예방 및 치료용 조성물
    8.
    发明公开
    월계수 잎의 단일성분 추출물을 함유한 파킨슨병과 퇴행성 신경계 뇌질환의 예방 및 치료용 조성물 无效
    通过使用其他化合物从LAURUS NOBILIS提取物处理和/或预防帕金森病和神经性脑病的组合物提取物

    公开(公告)号:KR1020100036052A

    公开(公告)日:2010-04-07

    申请号:KR1020080095486

    申请日:2008-09-29

    Inventor: 마응천 신종헌

    Abstract: PURPOSE: A composition for preventing and treating neurodegenerative diseases and Parkinson's disease containing Laurus nobilis leaves is provided to suppress apoptosis and intracellular ROS(reactive oxygen species) and reduce overexpression of active caspase-3 and a-synuclein. CONSTITUTION: A composition for preventing and treating Parkinson's disease and neurodegenerative disease contains single ingredient isolated from hexane layer and chloroform layer of Laurus nobilis leaves. The single ingredient is costunolide, dehydrocostuslactone or spirafolide, or 3 alpha-acetoxyeudesma-1,4(15),11(13)-triene-12,6alpha-olide. The single ingredient isolated from chloroform layer of Laurus nobilis leaves is reynosin.

    Abstract translation: 目的:提供一种用于预防和治疗神经变性疾病的组合物和含有金牛座叶的帕金森氏病,以抑制凋亡和细胞内ROS(活性氧),并减少活性半胱天冬酶-3和α-突触核蛋白的过表达。 构成:用于预防和治疗帕金森病和神经变性疾病的组合物含有从己烯层和金牛座叶氯仿层分离的单一成分。 单一成分是肋骨瓜内苷,脱氢放疗曲安奈德或曲安奈德,或3种α-乙酰胆固醇-1,4(15),11(13) - 三烯-12,6α-橄榄。 从金牛座叶子的氯仿层分离的单一成分是reynosin。

    세스퀴테르펜 화합물을 포함하는, 퇴행성 뇌질환의 예방 또는 치료용 조성물
    10.
    发明授权
    세스퀴테르펜 화합물을 포함하는, 퇴행성 뇌질환의 예방 또는 치료용 조성물 有权
    包含SESQUITERPENE化合物的组合物,用于预防或治疗变应性疾病

    公开(公告)号:KR101092620B1

    公开(公告)日:2011-12-13

    申请号:KR1020100055114

    申请日:2010-06-10

    CPC classification number: A61K31/365 A61K31/215 A61K36/54

    Abstract: PURPOSE: A composition containing sesquiterpene compound for preventing or treating neurodegenerative diseases is provided to suppress deformation of alpha-synuclein. CONSTITUTION: A composition for preventing or treating neurodegenerative diseases contains sesquiterpene of isozaluzanin C, magnolialide, santamarine, lucentolide, 1beta-hydroxyarbusculin A, and methyl 1beta, 2beta, 6 alpha-trihydroxy-5alpha,7alphaH-eudesma-4(15),11(13)-dien-12-oate as an active ingredient. The neurodegenerative diseases are Parkinson's disease, Alzheimer's disease, or Lewy body dementia. The sesquiterpene compound is isolated from chloroform of Laurus nobilis L.

    Abstract translation: 目的:提供含有用于预防或治疗神经变性疾病的倍半萜烯化合物的组合物,以抑制α-突触核蛋白的变形。 构成:用于预防或治疗神经退行性疾病的组合物包含异唑烷酮C,草甘膦,马铃薯碱,lucentolide,1beta-hydroxyarbusculin A和甲基1beta,2beta,6α-三羟基-5α,7αH-eudesma-4(15),11 (13) - 二烯-12-酸酯作为活性成分。 神经变性疾病是帕金森病,阿尔茨海默病或路易体痴呆。 倍半萜烯化合物从金牛座Laurus L.

Patent Agency Ranking